The University Of Texas Health Science Center At San Antonio
Clinical trials sponsored by The University Of Texas Health Science Center At San Antonio, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a phone call ease warzone headaches? new trial tests virtual therapy for veterans Results expected Sep 2026 (estimated)
- Can training make soldiers more resilient? new study seeks answers Results expected Sep 2026 (estimated)
- Soaking in sound waves: new study tests ultrasound baths for healthier aging Results expected Oct 2026 (estimated)
- Two new drugs join forces with chemo to tackle tough lymphoma Results expected Oct 2026 (estimated)
- Dust mite asthma study aims to uncover how dupilumab works inside the body Results expected Nov 2026 (estimated)
-
Lung cancer drug combo study halted after just 4 patients
Disease control Stopped earlyThis study aimed to see if combining two drugs, bemcentinib and pacritinib, could help people with advanced lung adenocarcinoma that had stopped responding to other treatments. Only 4 patients were enrolled before the study was terminated early, so no conclusions can be drawn abo…
Phase 1/2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Stomach cancer clues sought in hispanic population study
Knowledge-focused Stopped earlyThis study aimed to find genetic and lifestyle factors that increase stomach cancer risk in a mostly Hispanic population in South Texas. Researchers compared DNA from cancer tissue and saliva, and surveyed patients about diet, health history, and exposures. The goal was to unders…
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC